Global Healthcare, Lee
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced that the Company will present at the Leerink Global Healthcare Conference on Wednesday,
Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...
Thank you for joining us on day three, the final day of our global healthcare conference in beautiful, sunny Miami at the W Hotel. We’re very excited to have Exelixis with us. We have we’ll ...
Avacta Group plc ( ($GB:AVCT) ) has issued an announcement. Avacta Therapeutics announced its participation in the 2025 Leerink Global Healthcare ...
today announced that members of the Company’s management team will present at Leerink’s Global Healthcare Conference: Audio webcasts and replays of available presentations will be accessible ...
On Wednesday, 12 March 2025, Arcus Biosciences (NYSE: RCUS) participated in Leerink’s Global Healthcare Conference 2025. The company shared strategic insights into its clinical programs ...
today announced that the Company will present at the Leerink Global Healthcare Conference being held in Miami, FL on Tuesday, March 11, 2025 at 10:00 a.m. ET. A live webcast of the presentation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback